Latest Health News
Scilex Holding Company (Nasdaq: SCLX) Announces Its Majority-Owned Subsidiary, Semnur Pharmaceuticals, Inc. (Semnur), and Denali Capital Acquisition Corp. Have Entered into a Purchase Agreement with an Investor for a $20 Million Private Placement at $16.0
PALO ALTO, Calif., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company…
Advanz Pharma and Alvotech receive European approval for Mynzepli, Biosimilar to Eylea
Mynzepli® (aflibercept) is approved in all European Economic Area member countries for…
Novonesis delivered 9% organic sales growth in H1 and full-year outlook range narrowed to 6-8%
COPENHAGEN, Denmark – August 21, 2025. Novonesis delivered 9% organic sales growth…
Glaucoma Research Foundation Launches Treatment Accelerator with Transformative $5 Million Gift
SAN FRANCISCO, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Glaucoma Research Foundation is…
InfoAging Launches Floridas First Comprehensive Care Team Finder to Tackle Senior Health Crisis
August 20, 2025 10:00 ET | Source: InfoAging Miami, Florida, Aug. 20,…
Keros Announces U.S. FDA Orphan Drug Designation Granted to KER-065 for the Treatment of Duchenne Muscular Dystrophy
August 20, 2025 09:48 ET | Source: Keros Therapeutics, Inc. LEXINGTON, Mass.,…
MedX Holdings, Inc. (OTC: MEDH) Med X Holdings Q2 2025 Investor Update: Were at an Inflection Point
Austin, Texas, Aug. 19, 2025 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE MedX…
Tevogen Delivers Stronger Second Quarter and First Half 2025 Financial Results with Reduced Expenses and Growth Momentum
Expenses significantly lower with expansion on multiple efforts; Q2 2025 loss from…
IPSEN – Buy-back programme – Art 5 of MAR – Week 33 – 2025
Aggregated presentation by day and by marketStatement of transactions in own shares…
